Los Angeles Daily News Readership Names Valley Presbyterian Hospital “Best Hospital” for Sixteenth Consecutive Year

For the sixteenth year in a row, Valley Presbyterian Hospital (VPH) has been awarded the distinction of Best Hospital in the San Fernando Valley by Los Angeles Daily News readers.

“We are honored that the Daily News readers voted us the ‘Best Hospital’ in the Valley sixteen years in a row. Especially in a year where our community faced so many challenges, this award is a recognition that our commitment to their well-being is appreciated.” — Gustavo Valdespino, President and CEO of Valley Presbyterian Hospital.

Valley Presbyterian Hospital first opened its doors over 60 years ago as a small, neighborhood provider. While remaining as independent as in 1958, today VPH has grown into a 350-bed full-service, non-profit community hospital, dedicated to the health and well-being of the diverse and challenged communities of the San Fernando Valley.

The hospital’s enduring goal is to be a vital asset to the community because for VPH, this Valley is not just an area of operation, but their home. And its people are not just patients, they are friends, partners and community. VPH builds the facilities and services specifically focused on the needs of those in their patient community. VPH maintains services that help patients manage and improve their health by providing access to a wide array of education and support. Patients are treated with respect through listening intently so care is more effective. And VPH consistently invests in its people, the most vital asset of all, building greater teamwork and communication that raises the quality of care for all patients.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”